This is a type IV phase trial.
The SOLACE study will help us generate and advance scientific knowledge of real-life management of hidradenitis suppurativa and the condition’s burden on people with moderate to severe HS. It will aim to demonstrate the real-life effectiveness (how well something works) of HUMIRA on productivity, and physical and psychological quality of life. Finally, it will see how the use of HUMIRA affects patients’ use of health care resources (visit to hospital Emergency Room, hospitalization, help at home with regular activities, wound care, etc.) and associated costs in Canada.